Technology
Health
Pharmaceutical

Melinta Therapeutics

$3.81
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.23 (-5.50%) Today
-$0.14 (-3.54%) As of 5:41 PM EDT after-hours

Why Robinhood?

You can buy or sell MLNT and other stocks, options, ETFs, and crypto commission-free!

About MLNT

Melinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. Read More These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.

Employees
290
Headquarters
Morristown, New Jersey
Founded
2000
Market Cap
49.24M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.67M
High Today
$5.14
Low Today
$3.90
Open Price
$4.32
Volume
6.76M
52 Week High
$31.47
52 Week Low
$1.62

Collections

Technology
Health
Pharmaceutical
Therapy
US
North America

MLNT News

BenzingaJul 5

Make Trend Your Friend With This Volume-Focused Trading Tool

731
MarketWatchJun 19

Melinta Therapeutics' stock rockets on heavy volume after FDA accepts sNDA for Baxdela

5,704

MLNT Earnings

-$4.33
-$3.05
-$1.78
-$0.50
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 7, Pre-Market

More MLNT News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.